• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dan Klein Outlines Policy Changes to Strengthen the Safety Net

Video

Dan Klein, president and CEO of the Patient Access Network (PAN) Foundation, lists possible policy changes that would strengthen the safety net.

Dan Klein, president and CEO of the Patient Access Network (PAN) Foundation, lists possible policy changes that would strengthen the safety net.

Transcript

What policy changes are you looking to see that would strength the safety net?

One of the big changes we would like to see is spreading the out-of-pocket cost for Medicare patients throughout the benefit year rather than having it all hit in the beginning of the year. I think a lot of patients really could probably afford their out of pocket cost if they could spread it out. So, we’re hoping that there will be some attention towards that. We would also like to see at least one highly effective drug for each indication being placed on a non-specialty tier. So, having a copay rather than a coinsurance for at least one of the innovators specialty drugs for each indication. Then, of course, the third and one you hear more often is putting an out-of-pocket limit on the catastrophic phase in Medicare. We think that that would be helpful but it’s not gonna affect that many people. There’s only about 2% of Medicare beneficiaries who reach the catastrophic threshold.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.